|
21 Feb 2007 |
Bentley Announces Approval and Expansion of Its Nasulin Phase II Studies in India
|
|
21 Feb 2007 |
Dyax and Genzyme Announce Agreement to Terminate Joint Venture for the Commercialization of DX-88 in HAE
|
|
17 Feb 2007 |
OrthoLogic Announces Results of Post Hoc Subgroup Analysis of Data From Phase 3 Clinical Trial of Chrysalin (TP508) in Fracture Repair
|
|
16 Feb 2007 |
Stem Cell Sciences and Celogos Sign a Licensing Deal on Autogenous Myoblast Transplantation For Urinary Incontinence Therapy
|
|
16 Feb 2007 |
FDA Accepts ZymoGenetics' Recombinant Human Thrombin Application for Review
|
|
15 Feb 2007 |
Halozyme and Baxter Expand Global HYLENEX Collaboration
|
|
15 Feb 2007 |
Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX from the Infuse-Morphine Study
|
|
14 Feb 2007 |
Sangart, Inc. Initiates Phase III Clinical Trials
|
|
13 Feb 2007 |
Ambrx Initiates Phase I/II Clinical Trial of Novel Human Growth Hormone Product Candidate
|
|
13 Feb 2007 |
QSV Biologics, Ltd., and Critical Biologics Corp., Sign Contract for cGMP Manufacture of Gelsolin for Critical Care Applications
|
|
09 Feb 2007 |
Zelos Therapeutics' Ostabolin-CTM Increases Bone Mineral Density in Phase 2 Osteoporosis Trial
|
|
09 Feb 2007 |
EU-Approval for Continuous Infusion of KOGENATE(R) Bayer
|
|
09 Feb 2007 |
LAB International Completes Patient Enrollment in Its Growth Hormone Releasing Hormone (GHRH) Product Phase IIA Trial
|
|
09 Feb 2007 |
Amarillo Biosciences Announces Open Enrollment in Its Phase 2 Study of Orally Administered Interferon Alpha in the Treatment of Oral Warts in HIV-Positive Patients
|
|
09 Feb 2007 |
Presentations at Stroke Conference Update Development of Viprinex(TM) (ancrod)
|
|
07 Feb 2007 |
Jerini expands collaboration with Baxter to develop non-intraveneous hemophilia therapy
|
|
07 Feb 2007 |
Gloucester Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial in Patients with Multiple Myeloma
|
|
06 Feb 2007 |
Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
|
|
06 Feb 2007 |
Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies
|
|
03 Feb 2007 |
Adnexus Therapeutics Announces Presentation Of Interim Phase I Results For CT-322, First Adnectin Therapeutic In Humans
|
|
02 Feb 2007 |
Overview On 2006 Sales Of TOP 20 Biologics To Be Released On February 26
|
|
02 Feb 2007 |
Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline
|
|
02 Feb 2007 |
Grifols announces FDA approval of Alphanate(R) to treat von Willebrand disease
|
|
02 Feb 2007 |
Successful Oral Insulin Toxicity Result - Oradel(TM), Loaded With Generic Insulin
|
|
31 Jan 2007 |
Gloucester Pharmaceuticals Receives Special Protocol Assessment for Pivotal Phase II Trial of Romidepsin in Patients with Peripheral T-Cell Lymphoma
|
